RENAISSANCE TECHNOLOGIES LLC

Position in GALT — Galectin Therapeutics Inc

CIK 1037389 NEW YORK, NY

Position in GALT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$201,111

-$211,530 QoQ

Shares Held

43,343

-70.7% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 98 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. GALT ranks #254 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$201,111	43,343	-70.7%	Shares	Sole	2026-08-13
2026-03-31	$412,641	147,900	+433.9%	Shares	Sole	2026-05-14
2022-06-30	$36,287	27,700	-86.3%	Shares	Sole	2022-08-12
2022-03-31	$325,248	202,018	-6.2%	Shares	Sole	2022-05-13
2021-12-31	$445,878	215,400	+2033.5%	Shares	Sole	2022-02-11
2021-09-30	$39,172	10,096	-97.3%	Shares	Sole	2021-11-12
2021-06-30	$1,184,636	370,199	+20.6%	Shares	Sole	2021-08-13
2021-03-31	$666,190	307,000	+1864.5%	Shares	Sole	2021-05-13
2020-12-31	$35,004	15,627	-22.3%	Shares	Sole	2021-02-10
2020-03-31	$39,396	20,100	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.